BB Biotech AG (XSWX:BION) Forward Dividend Yield %: 4.81% (As of Jun. 26, 2026)


XSWX:BION BB Biotech AG XSWX:BION
33 GF Score
Price CHF47.80
! 3 Warning Signs
View Full Analysis

What is BB Biotech AG Forward Dividend Yield %?

BB Biotech AG XSWX:BION +2.14% 33 Forward Dividend Yield % is 4.81% as of Jun. 26, 2026. GuruFocus rates XSWX:BION with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 146 Biotechnology companies, BB Biotech AG ranks better than 80.14% on this metric.

As of today (2026-06-26), the Forward Annual Dividend Yield of BB Biotech AG is 4.81%.

As of today (2026-06-26), the Trailing Annual Dividend Yield of BB Biotech AG is 4.81%.

XSWX:BION's Forward Dividend Yield % is ranked better than
80.14% of 146 companies
in the Biotechnology industry
Industry Median: 1.495 vs XSWX:BION: 4.81

BB Biotech AG's Dividends per Share for the three months ended in Mar. 2026 was CHF2.25.

During the past 12 months, BB Biotech AG's average Dividends Per Share Growth Rate was 25.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -22.40% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -13.90% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -2.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of BB Biotech AG was 52.60% per year. The lowest was -27.90% per year. And the median was 6.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


BB Biotech AG  (XSWX:BION) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


BB Biotech AG Forward Dividend Yield % Related Terms


XSWX:BION vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, BB Biotech AG's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Forward Dividend Yield % falls into.


XSWX:BION
33GF Score
BB Biotech AG XSWX:BION
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

BB Biotech AG Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
CHF 2.2500002026-03-232026-03-242026-03-25Cash DividendannuallyCHF:CHF 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

BB Biotech AG's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=2.25/47.80
=4.71 %

Current Share Price is CHF47.80.
BB Biotech AG's Dividends per Share for the forward twelve months is calculated as CHF2.25 * 1 = CHF2.25.

BB Biotech AG's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=2.25/47.80
=4.71 %

Current Share Price is CHF47.80.
BB Biotech AG's Dividends per Share for the trailing twelve months (TTM) ended in Today is CHF2.25.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 4.81% mean?
BB Biotech AG (XSWX:BION) has a Forward Dividend Yield % of 4.81% as of Jun. 26, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on BB Biotech AG and its competitors. According to the industry distribution chart, BB Biotech AG ranks #29 out of 146 companies in the Biotechnology industry, placing it in the top 19.9%.
Is BB Biotech AG's Forward Dividend Yield % too high?
BB Biotech AG's current Forward Dividend Yield % is 4.81%. The Biotechnology industry median Forward Dividend Yield % is 1.50. BB Biotech AG's value of 4.81% is 221.7% above this industry median. Based on the distribution chart, BB Biotech AG ranks #29 out of 146 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, BB Biotech AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #29 out of 146 companies for Forward Dividend Yield %. This places BB Biotech AG in the top 20% of its industry — outperforming the majority of peers. The industry median Forward Dividend Yield % is 1.50. BB Biotech AG's value of 4.81% is 221.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.50, based on 146 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BB Biotech AG's current Forward Dividend Yield % of 4.81% is 221.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on BB Biotech AG and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BB Biotech AG's current Forward Dividend Yield % is 4.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current Forward Dividend Yield % of 4.81%. The current Forward Dividend Yield % is 4.81% and 221.7% above the Biotechnology industry median of 1.50. BB Biotech AG's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current Forward Dividend Yield % is 4.81% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
33GF Score

Get the complete analysis for XSWX:BION

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF47.80
Price